FDA Doesn’t Have The Discretion It Thought It Had

Law360, New York (April 26, 2012, 1:28 PM EDT) -- Of all the areas in which we’d have expected to see the U.S. Food and Drug Administration's (FDA) discretionary wings clipped, drugs used in lethal injection executions didn’t come to mind. But we recently read Beaty v. FDA, 2012 U.S. Dist. LEXIS 41397 (D.D.C. Mar. 27, 2002), and that’s exactly what it involved. It provides an unexpected but indisputably interesting backdrop for the discussion.

In Beaty, a group of death row inmates challenged the FDA’s decision to allow certain states to use thiopental, an anesthesia drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.